Global Fund to Fight AIDS Tuberculosis and Malaria - Institutional Support 2017-2019

This grant represents Canada’s long-term institutional support to the Global Fund to Fight AIDS Tuberculosis and Malaria. The Global Fund to Fight AIDS Tuberculosis and Malaria uses these funds along with other donors’ funding to achieve its mandate. The Global Fund to Fight AIDS Tuberculosis and Malaria is a unique public-private partnership and international financing institution dedicated to attracting and disbursing additional resources to prevent and treat AIDS tuberculosis and malaria. It is a partnership between governments civil society the private sector and affected communities which represents an innovative approach to international health financing. The Global Fund’s model is based on the concepts of country ownership and performance-based funding which means that organizations in developing countries implement their own programs based on their own priorities and must be able to show what results have been achieved. Since its creation in 2002 the Global Fund has become the main global financier of programs to fight AIDS tuberculosis and malaria with approved funding in more than 100 countries. This grant contributes towards meeting the Sustainable Development Goal target of eliminating HIV tuberculosis and malaria as epidemics by 2030 by supporting countries to scale up treatment and prevention services. This grant also contributes to improving the health and rights of women and children (including adolescents) and focuses international assistance efforts on helping the poorest and most vulnerable.

The expected results are defined by the “Global Fund Strategy 2017-2022”. This strategy includes the following targets to be achieved by 2020: (1) 90% of persons living with HIV (PLHIV) know their status 90% PLHIV who know their status and receiving treatment; and 90% of people on treatment have suppressed viral loads; (2) a 20% and 35% decline in TB incidence rate and TB deaths respectively compared with 2015; and (3) at least a 40% reduction in malaria mortality rates and malaria case incidence compared with 2015.